Table 1.

Evolution of laboratory findings in patients with hyperinflammatory state

	At diagnosis of COVID-19			At ruxolitinib start			Day 8 of ruxolitinib			Day 15 of ruxolitinib
	CRP, mg/dL	ferritin, ng/mL	D-dimer, ng/mL	CRP, mL mg/ferritin, ng/mL		D-dimer, ng/mL	CRP, mg/dL	ferritin, ng/mL	D-dimer, ng/mL	CRP, mg/dL	ferritin, ng/mL	D-dimer, ng/mL	COVID-19 PCR
Case 1	2	2,051	856	20	7,231	1,009	16	2,052	890	0.5	1,006	300	negative
Case 2	3	1,090	1,500	13	3,209	658	4	4,506	1,185	5	802	201	negative
Case 3	5	2,111	905	16	3,540	1,508	14	4,211	2,241	1.57	2,364	568	negative